Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 10-2010 | 12-2009 | 10-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48 | 1 | 0 | 0 | 0 |
| TOTAL | $78 | $1 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 25 | 2 | 0 | 4 | 0 |
| TOTAL | $25 | $2 | $0 | $4 | $0 |
| Total Assets | $103 | $3 | $0 | $4 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1 | N/A | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 1,015 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 12 | 66 | 0 | 9 | 0 |
| Other current liabilities | 429 | N/A | 0 | N/A | 0 |
| TOTAL | $1,457 | $78 | $0 | $20 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 13 | 0 | 12 | 0 |
| Other Non-Current Liabilities | 180 | 0 | 0 | 0 | 0 |
| TOTAL | $180 | $13 | $0 | $12 | $0 |
| Total Liabilities | $1,638 | $78 | $0 | $20 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 73 | N/A | N/A | N/A |
| Common Shares | 4 | 11 | 0 | 11 | 0 |
| Retained earnings | -2,286 | -102 | 0 | -44 | 0 |
| Other shareholders' equity | 685 | 0 | 0 | 0 | 0 |
| TOTAL | $-1,535 | $-75 | $0 | $-16 | $0 |
| Total Liabilities And Equity | $103 | $3 | $0 | $4 | $0 |